DWTX

Dogwood Therapeutics
DWTX

Overview Fund Trends Analyst Outlook Journalist POV
6.01 USD
--0.04
0.66%
At close Updated Oct 16, 4:00 PM EDT
Pre-market
After hours
6.00
--0.01
0.17%
1 day
-0.66%
5 days
10.68%
1 month
23.16%
3 months
33.56%
6 months
61.13%
Year to date
139.44%
1 year
35.67%
5 years
-98.56%
10 years
-98.56%
 

About: Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Employees: 12

Healthcare Biotechnology
0
Funds holding %
of 7,495 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
0
Positive news %
of 4 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™